About 100 reports

  • PROSPECTS

The self-management of mild digestive problems is expected to remain a major driver, which will be further supported by the increasing incidence of gastrointestinal problems due to higher levels of stress, rich eating habits and lack of exercise routine.

  • Gastrointestinal Drug
  • India
  • Demand
  • Dabur India Limited
  • GlaxoSmithKline plc
  • COMPETITIVE LANDSCAPE
  • TRENDS

This expectancy is related to the shopping behaviour of many consumers regarding products affecting their gastrointestinal health.

  • Gastrointestinal Drug
  • Weight Loss
  • Germany
  • Demand
  • GlaxoSmithKline plc
  • HEADLINES
  • PROSPECTS

Irritable Bowel Syndrome or IBS is a common chronic gastrointestinal disorder.

  • Gastrointestinal Drug
  • Canada
  • Bayer AG
  • Jamieson Laboratories Ltd.
  • Valeant Pharmaceuticals International, Inc.
  • TRENDS

Younger consumers are also turning to gastrointestinal drugs, although most of their purchases in this category relate to broad spectrum painkillers.

  • Gastrointestinal Drug
  • OTC
  • Poland
  • Demand
  • GlaxoSmithKline plc
  • PROSPECTS

The category is set to continue to benefit from the increasing incidence of gastrointestinal problems due to higher levels of stress, the ageing population and more variable weather patterns linked to climate change.

  • Gastrointestinal Drug
  • OTC
  • Portugal
  • Demand
  • Pfizer Inc.
  • COMPETITIVE LANDSCAPE

Irritable Bowel Syndrome (IBS) is an increasingly common chronic gastrointestinal disorder, which according to the Mexican Association of Gastroenterology, affects between ##% and ##% of the population.

  • Gastrointestinal Drug
  • OTC
  • Mexico
  • Demand
  • Farmacias Similares SA
  • TRENDS

Value sales were fuelled by the rising number of people suffering from gastrointestinal problems related to unhealthy lifestyles.

  • Gastrointestinal Drug
  • OTC
  • Netherlands
  • Demand
  • Clinical Trial Product Information
  • Trial Results

PROPORTION OF NONEROSIVE REFLUX DISEASE (NERD) TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2015* PROPORTION OF NONEROSIVE REFLUX DISEASE (NERD) TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2015* PROPORTION OF NONEROSIVE REFLUX DISEASE (NERD) TO

  • Gastrointestinal Drug
  • World
  • ALTANA AG
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited

They have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics.

  • Gastrointestinal Drug
  • China
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited
  • Tianjin Pharmaceutical Co., Ltd.

GASTROINTESTINAL (GI) DISORDERS ##. ##. ##.

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Market Size
  • MicroBiome Therapeutics LLC
  • TRENDS

STRESS CAN BOTH INDUCE AND WORSEN GASTROINTESTINAL UPSET, AND IS LINKED TO NAUSEA, INDIGESTION, HEARTBURN AND THE DEVELOPMENT OF ULCERS.

  • Gastrointestinal Drug
  • United States
  • Demand
  • Bayer AG
  • CVS Caremark Corporation
  • 5.2 ABBREVIATIONS

" I think Xifaxan would definitely be picked up more by local GI [gastrointestinal] doctors and by community providers, because they just do not use it [only] for IBS, and if it is FDA [Food and Drug Administration]-approved, they would be much more likely to use it.

  • Gastrointestinal Drug
  • Actavis plc
  • Almirall, S.A.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • TRENDS

Younger consumers are also turning to gastrointestinal drugs, although most of their purchases in this category relate to broad spectrum painkillers.

  • Gastrointestinal Drug
  • OTC
  • Poland
  • Demand
  • GlaxoSmithKline plc
  • Safety of Lotronex - Most Frequently Reported Adverse Events
  • Disease Management

Identification of sub-groups of functional gastrointestinal disorders.

  • Gastrointestinal Drug
  • Pharmaceutical
  • Japan
  • Forecast
  • Actavis plc
  • Disease Management
  • PRESENTS THE MOST COMMON SYMPTOMS OF IBS.

IDENTIFICATION OF SUB-GROUPS OF FUNCTIONAL GASTROINTESTINAL DISORDERS.

  • Gastrointestinal Drug
  • Forecast
  • Actavis plc
  • Ardelyx, Inc.
  • AstraZeneca PLC
  • Disease Management
  • COMMON SYMPTOMS OF IBS

IDENTIFICATION OF SUB-GROUPS OF FUNCTIONAL GASTROINTESTINAL DISORDERS.

  • Gastrointestinal Drug
  • World
  • Forecast
  • Actavis plc
  • Furiex Pharmaceuticals, Inc.
  • Disease Management
  • COMMON SYMPTOMS OF IBS

IDENTIFICATION OF SUB-GROUPS OF FUNCTIONAL GASTROINTESTINAL DISORDERS.

  • Gastrointestinal Drug
  • World
  • Forecast
  • Actavis plc
  • Menarini Group

The core business of the company is generic medicines, with it covering a wide range of therapeutic areas, including medicines for the treatment of infections, cardiovascular and central nervous system diseases, analgesics, gastrointestinal preparations and products for women' s health.

  • Gastrointestinal Drug
  • OTC
  • Czech Republic
  • Demand
  • Zentiva NV
  • Disease Management
  • COMMON SYMPTOMS OF IBS

IDENTIFICATION OF SUB-GROUPS OF FUNCTIONAL GASTROINTESTINAL DISORDERS.

  • Gastrointestinal Drug
  • Therapy
  • World
  • Forecast
  • Actavis plc
  • Disease Management
  • COMMON SYMPTOMS OF IBS

IDENTIFICATION OF SUB-GROUPS OF FUNCTIONAL GASTROINTESTINAL DISORDERS.

  • Gastrointestinal Drug
  • World
  • Forecast
  • Actavis plc
  • Salix Pharmaceuticals, Ltd.
  • COMPETITIVE LANDSCAPE

gastrointestinal ailments, following the consumption of unhealthy drinks and contaminated food.

  • Gastrointestinal Drug
  • OTC
  • Bolivia
  • Demand
  • TRENDS

In addition, stressful and fast-paced lifestyles, with tight schedules and traffic jams, impact the digestive system, causing tension, which is reflected in gastrointestinal discomfort.

  • Gastrointestinal Drug
  • OTC
  • Colombia
  • Demand
  • Tecnoquímicas SA
  • Disease Management
  • 3.3 SYMPTOMS

Identification of sub-groups of functional gastrointestinal disorders.

  • Gastrointestinal Drug
  • Therapy
  • Japan
  • Forecast
  • Astellas Pharma Inc.
  • Disease Management
  • 7.2 ABBREVIATIONS

Identification of sub-groups of functional gastrointestinal disorders.

  • Gastrointestinal Drug
  • Therapy
  • Japan
  • United States
  • Sucampo Pharmaceuticals, Inc.
  • Disease Management
  • 7.2 ABBREVIATIONS

Identification of sub-groups of functional gastrointestinal disorders.

  • Gastrointestinal Drug
  • Japan
  • Almirall, S.A.
  • Astellas Pharma Inc.
  • Ironwood Pharmaceuticals, Inc.
  • TREATMENT GUIDELINES FOR IBS
  • IBS DIAGNOSIS AND TREATMENT, COUNTRY PROFILE - JAPAN

" I think Xifaxan would definitely be picked up more by local GI [gastrointestinal] doctors and by community providers, because they just do not use it [only] for IBS, and if it is FDA [Food and Drug Administration]-approved, they would be much more likely to use it.

  • Gastrointestinal Drug
  • Japan
  • Actavis plc
  • Ardelyx, Inc.
  • Furiex Pharmaceuticals, Inc.
  • SAFETY OF LOTRONEX - MOST FREQUENTLY REPORTED ADVERSE EVENTS
  • COMMON SYMPTOMS OF IBS

" I think Xifaxan would definitely be picked up more by local GI [gastrointestinal] doctors and by community providers, because they just do not use it [only] for IBS, and if it is FDA [Food and Drug Administration]-approved, they would be much more likely to use it.

  • Gastrointestinal Drug
  • United States
  • Actavis plc
  • Ardelyx, Inc.
  • Furiex Pharmaceuticals, Inc.
  • COMMON SYMPTOMS OF IBS
  • 3.3 SYMPTOMS

" I think Xifaxan would definitely be picked up more by local GI [gastrointestinal] doctors and by community providers, because they just do not use it [only] for IBS, and if it is FDA [Food and Drug Administration]-approved, they would be much more likely to use it.

  • Gastrointestinal Drug
  • Europe
  • Actavis plc
  • Ardelyx, Inc.
  • Furiex Pharmaceuticals, Inc.
  • 4.1 BIBLIOGRAPHY
  • 2.1 CATALYST

U. S. householder survey of functional gastrointestinal disorders.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Italy
  • Forecast
  • DATA PARAMETERS AND DEFINITIONS (1)
  • UNHEALTHY LIFESTYLE TRENDS

The gut is especially vulnerable to tension and can demonstrate stress-induced physiological changes causing gastrointestinal discomfort.

  • Gastrointestinal Drug
  • World
  • Demand
  • Procter & Gamble Company
  • Sanofi S.A.